Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry

Hofmann A F
September 2003
Gut;Sep2003, Vol. 52 Issue 9, p1239
Academic Journal
No abstract available.


Related Articles

  • Bile Acids: Chemistry, Pathochemistry, Biology, Pathobiology, and Therapeutics. Hofmann, A.; Hagey, L. // Cellular & Molecular Life Sciences;Aug2008, Vol. 65 Issue 16, p2461 

    Bile acids and bile alcohols in the form of their conjugates are amphipathic end products of cholesterol metabolism with multiple physiological functions. The great variety of bile acids and bile alcohols that are present in vertebrates are tabulated. Bile salts have an enterohepatic circulation...

  • Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress. Bochkis, Irina M.; Rubins, Nir E.; White, Peter; Furth, Emma E.; Friedman, Joshua R.; Kaestner, Klaus H. // Nature Medicine;Aug2008, Vol. 14 Issue 8, p828 

    Production of bile by the liver is crucial for the absorption of lipophilic nutrients. Dysregulation of bile acid homeostasis can lead to cholestatic liver disease and endoplasmic reticulum (ER) stress. We show by global location analysis ('ChIP-on-chip') and cell type–specific gene...

  • Hepatic Cannabinoid Receptor Type 1 Mediates Alcohol-Induced Regulation of Bile Acid Enzyme Genes Expression Via CREBH. Chanda, Dipanjan; Kim, Yong-Hoon; Li, Tiangang; Misra, Jagannath; Kim, Don-Kyu; Kim, Jung Ran; Kwon, Joseph; Jeong, Won-Il; Ahn, Sung-Hoon; Park, Tae-Sik; Koo, Seung-Hoi; Chiang, John Y L.; Lee, Chul-Ho; Choi, Hueng-Sik // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    Bile acids concentration in liver is tightly regulated to prevent cell damage. Previous studies have demonstrated that deregulation of bile acid homeostasis can lead to cholestatic liver disease. Recently, we have shown that ER-bound transcription factor Crebh is a downstream effector of hepatic...

  • Circadian Dysregulation Disrupts Bile Acid Homeostasis. Ke Ma; Rui Xiao; Hsiu-Ting Tseng; Lu Shan; Loning Fu; Moore, David D. // PLoS ONE;2009, Vol. 4 Issue 8, p1 

    Background: Bile acids are potentially toxic compounds and their levels of hepatic production, uptake and export are tightly regulated by many inputs, including circadian rhythm. We tested the impact of disrupting the peripheral circadian clock on integral steps of bile acid homeostasis....

  • Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. Yaping Liu, Jane; Binz, Mary Jo; Numerick, Steve; Dennis; Guizhen Luo; Bhasha Desai, Kathleen I.; MacKenzie, Traci A.; Mansfield, Steven A.; Kliewer, Bryan; Goodwin, Stacey A.; Jones // Journal of Clinical Investigation;Dec2003, Vol. 112 Issue 11, p1678 

    Farnesoid X receptor (FXR) is a bile acid-activated transcription factor that is a member of the nuclear hormone receptor superfamily. Fxr-null mice exhibit a phenotype similar to Byler disease, an inherited cholestatic liver disorder. In the liver, activation of FXR induces transcription of...

  • Use of ursodeoxycholic acid in patients with hypertransaminasemia. Puoti, Claudio; Elmo, Maria Giuseppa // Italian Journal of Medicine;2014, Vol. 8 Issue 3, p141 

    Ursodeoxycholic acid (UDCA) is a hydrophilic bile acid deriving from 7β epimerization of primary bile compound chenodeoxycholic acid. It may have antioxidant, immunomodulatory, antifibrotic and cytoprotective effects, therefore it has been extensively used in the treatment of cholestatic...

  • The cholecystocolic bypass with jejunal interposition graft for bile acid depletion in bile and portal blood in guinea pigs. Delarue, A.; Gerhardt, M. F.; Merrot, T.; Roquelaure, B.; Guys, J. M.; Trivin, F. // Pediatric Surgery International;Jul2003, Vol. 19 Issue 5, p371 

    Ileal bypass and cholecystostomy are used in children with selected cholestatic diseases to lower the bile acid (BA) levels in bile and blood and improve outcome. The efficacy of a cholecystocolic bypass in achieving the same goals was investigated in guinea pigs. In the study group (n=7), a...

  • Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics. Davis, Mellar // Clinical Pharmacokinetics;2007, Vol. 46 Issue 10, p825 

    A class of endogenous opioids is upregulated in liver disease particular to cholestasis, which contributes to symptoms in liver disease such as pruritus, hypotension and encephalopathy. Symptoms associated with cholestasis are reversed or at least ameliorated by mu opioid receptor antagonists....

  • Anabolic steroids abuse.  // Reactions Weekly;Nov2014, Vol. 1524 Issue 1, p32 

    The article presents a case study of a 41-year old male patient who developed various toxicities including severe cholestatic liver disease, bile acid nephropathy leading to acute kidney injury (AKI) after abusing anabolic steroids.

  • Recent advances in pathogenesis and management of pruritus in cholestatic liver disease. WANG Man; SUN Fengxia // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;nov2014, Vol. 30 Issue 11, p1208 

    Pruritus is one of the common clinical manifestations of cholestatic liver diseases such as primary biliary cirrhosis, primary sclerosing cholangitis, and intrahepatic cholestasis of pregnancy. Potential incentives of itching include bile salts, histamine, progesterone metabolites, endogenous...


Read the Article


Sign out of this library

Other Topics